104 related articles for article (PubMed ID: 38942292)
21. Dissolution performance of binary amorphous drug combinations--Impact of a second drug on the maximum achievable supersaturation.
Trasi NS; Taylor LS
Int J Pharm; 2015 Dec; 496(2):282-90. PubMed ID: 26456250
[TBL] [Abstract][Full Text] [Related]
22. A win-win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability.
Miller JM; Beig A; Carr RA; Spence JK; Dahan A
Mol Pharm; 2012 Jul; 9(7):2009-16. PubMed ID: 22632106
[TBL] [Abstract][Full Text] [Related]
23. Impact of Micellar Surfactant on Supersaturation and Insight into Solubilization Mechanisms in Supersaturated Solutions of Atazanavir.
Indulkar AS; Mo H; Gao Y; Raina SA; Zhang GGZ; Taylor LS
Pharm Res; 2017 Jun; 34(6):1276-1295. PubMed ID: 28352994
[TBL] [Abstract][Full Text] [Related]
24. Equilibrium state at supersaturated drug concentration achieved by hydroxypropyl methylcellulose acetate succinate: molecular characterization using (1)H NMR technique.
Ueda K; Higashi K; Yamamoto K; Moribe K
Mol Pharm; 2015 Apr; 12(4):1096-104. PubMed ID: 25723893
[TBL] [Abstract][Full Text] [Related]
25. Glass-liquid phase separation in highly supersaturated aqueous solutions of telaprevir.
Mosquera-Giraldo LI; Taylor LS
Mol Pharm; 2015 Feb; 12(2):496-503. PubMed ID: 25541813
[TBL] [Abstract][Full Text] [Related]
26. Influence of additives on the properties of nanodroplets formed in highly supersaturated aqueous solutions of ritonavir.
Ilevbare GA; Liu H; Pereira J; Edgar KJ; Taylor LS
Mol Pharm; 2013 Sep; 10(9):3392-403. PubMed ID: 23829687
[TBL] [Abstract][Full Text] [Related]
27. Quantitative Analysis of Drug Supersaturation Region by Temperature-Variable Nuclear Magnetic Resonance Measurements, Part 1: Effects of Polymer and Drug Chiralities.
Ueda K; Higashi K; Moribe K
Mol Pharm; 2023 Apr; 20(4):1861-1871. PubMed ID: 36939575
[TBL] [Abstract][Full Text] [Related]
28. Impact of Drug-Rich Colloids of Itraconazole and HPMCAS on Membrane Flux in Vitro and Oral Bioavailability in Rats.
Stewart AM; Grass ME; Brodeur TJ; Goodwin AK; Morgen MM; Friesen DT; Vodak DT
Mol Pharm; 2017 Jul; 14(7):2437-2449. PubMed ID: 28591516
[TBL] [Abstract][Full Text] [Related]
29. The relevance of co-amorphous formulations to develop supersaturated dosage forms: In-vitro, and ex-vivo investigation of Ritonavir-Lopinavir co-amorphous materials.
Sai Krishna Anand V; Sakhare SD; Navya Sree KS; Nair AR; Raghava Varma K; Gourishetti K; Dengale SJ
Eur J Pharm Sci; 2018 Oct; 123():124-134. PubMed ID: 30048798
[TBL] [Abstract][Full Text] [Related]
30. Thermodynamics of Highly Supersaturated Aqueous Solutions of Poorly Water-Soluble Drugs-Impact of a Second Drug on the Solution Phase Behavior and Implications for Combination Products.
Trasi NS; Taylor LS
J Pharm Sci; 2015 Aug; 104(8):2583-93. PubMed ID: 26059413
[TBL] [Abstract][Full Text] [Related]
31. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.
Jackson MJ; Kestur US; Hussain MA; Taylor LS
Mol Pharm; 2016 Jan; 13(1):223-31. PubMed ID: 26618718
[TBL] [Abstract][Full Text] [Related]
32. Supersaturation and phase behavior during dissolution of amorphous solid dispersions.
Kong Y; Wang W; Wang C; Li L; Peng D; Tian B
Int J Pharm; 2023 Jan; 631():122524. PubMed ID: 36549404
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Pazopanib Phase Behavior Following pH-Induced Supersaturation.
Sugihara H; Taylor LS
Mol Pharm; 2018 Apr; 15(4):1690-1699. PubMed ID: 29502424
[TBL] [Abstract][Full Text] [Related]
34. Comparisons of
Sabra R; Narula A; Taylor LS; Li N
Mol Pharm; 2022 Sep; 19(9):3412-3428. PubMed ID: 35972995
[TBL] [Abstract][Full Text] [Related]
35. Effect of Drug-Polymer Interactions through Hypromellose Acetate Succinate Substituents on the Physical Stability on Solid Dispersions Studied by Fourier-Transform Infrared and Solid-State Nuclear Magnetic Resonance.
Ishizuka Y; Ueda K; Okada H; Takeda J; Karashima M; Yazawa K; Higashi K; Kawakami K; Ikeda Y; Moribe K
Mol Pharm; 2019 Jun; 16(6):2785-2794. PubMed ID: 31045376
[TBL] [Abstract][Full Text] [Related]
36. Practical Approach to Modeling the Impact of Amorphous Drug Nanoparticles on the Oral Absorption of Poorly Soluble Drugs.
Stewart AM; Grass ME
Mol Pharm; 2020 Jan; 17(1):180-189. PubMed ID: 31743032
[TBL] [Abstract][Full Text] [Related]
37. Enhancements and limits in drug membrane transport using supersaturated solutions of poorly water soluble drugs.
Raina SA; Zhang GGZ; Alonzo DE; Wu J; Zhu D; Catron ND; Gao Y; Taylor LS
J Pharm Sci; 2014 Sep; 103(9):2736-2748. PubMed ID: 24382592
[TBL] [Abstract][Full Text] [Related]
38. Supersaturated polymeric micelles for oral cyclosporine A delivery.
Yu H; Xia D; Zhu Q; Zhu C; Chen D; Gan Y
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1325-36. PubMed ID: 23954511
[TBL] [Abstract][Full Text] [Related]
39. Tailoring supersaturation from amorphous solid dispersions.
Li N; Taylor LS
J Control Release; 2018 Jun; 279():114-125. PubMed ID: 29654798
[TBL] [Abstract][Full Text] [Related]
40. Impact of Eudragit EPO and hydroxypropyl methylcellulose on drug release rate, supersaturation, precipitation outcome and redissolution rate of indomethacin amorphous solid dispersions.
Xie T; Gao W; Taylor LS
Int J Pharm; 2017 Oct; 531(1):313-323. PubMed ID: 28844901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
